http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2363616-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89df1827de2715e4a4d4358ac37677bd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-555
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39566
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
filingDate 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45f93b4f99613c9503b8da7e39fe36c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1a7caae89a401f66f3f658cd8e96a55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed68f28cb9d171bf806f4b22602cca45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b664fd19145f0b03b71583104ef44513
publicationDate 2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2363616-T3
titleOfInvention PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-CA125 ANTIDIOTYPIC MONOCLONAL ANTIBODY AND ALUMINUM.
abstract Pharmaceutical composition for parenteral administration as a vaccine, comprising a monoclonal antibody and as an adjuvant an aluminum derivative at a concentration between 2.4 and 5.2 mg / ml of aluminum ion, wherein - said monoclonal antibody is the antibody monoclonal anti-idiotypic anti-CA-125 MEN2234 comprising SEQ ID No. 1 and SEQ ID No. 2, and is present in an amount of 0.1-4 mg / ml and adsorbed on the aluminum derivative; and said aluminum compound is chosen from aluminum hydroxide and aluminum phosphate, and is suspended in a buffered aqueous system; characterized in that said pharmaceutical composition contains 1 ml of the product to be administered.
priorityDate 2006-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16693906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447917096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449122806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453694953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454519146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6336693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225616

Total number of triples: 41.